Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Completes Dionex Buy, Acquires Sterilin

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific said after the close of the market on Tuesday that it has completed the $2.1 billion purchase of chromatography firm Dionex through a short-form merger.

Today, Thermo Fisher also announced it has acquired Sterilin, a provider of single-use plastic products, for an undisclosed amount.

Pursuant to the terms of the Dionex merger, all shares of the company will be exchanged for $118.50 per share. Dionex's stock ceased trading on Nasdaq after the close of the market today, and will be delisted.

Thermo Fisher had completed the tender offer for Dionex last Friday, following clearance from the European Union.

Commenting on the Sterilin acquisition, Marc Casper, president and CEO of Thermo Fisher, said in a statement that it broadens the range of specialty laboratory products that the firm offers. The business will be integrated into Thermo Fisher's Laboratory Products and Services segment.

Based in South Wales, UK, Sterilin posted $35 million in revenues in 2010 and has about 270 employees. Its products serve the microbiology, life sciences, and clinical markets.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.